Ask Aeroz

Type the question you actually came here with.

EU FMD · Parallel distributors

The EU FMD for parallel distributors.

Under the EU Falsified Medicines Directive, a parallel distributor that repackages or relabels a medicine places equivalent safety features on the pack, uploads the new identifiers to the European Hub, and carries the repository duties of a marketing authorisation holder.

A parallel distributor buys a medicine in one EU market and sells it in another, often after repackaging or relabelling it. Under the EU FMD it may cover or remove the original safety features, but it must place equivalent ones: a new unique identifier and an anti-tampering device. It uploads the new identifiers to the European Hub, and before it opens a pack it must verify that the original identifier and seal are authentic.

Directive 2001/83/ECArticle 47aReg. (EU) 2016/161Equivalent featuresIn force
Key facts · reviewed

EU FMD for parallel distributors, in three facts.

Directive 2001/83/EC Article 47a · Reg. (EU) 2016/161 Articles 33 and 40 to 42 · equivalent safety features · re-seal only after the original pack is verified.

What the rule requires

Open the pack, keep the proof.

Equivalent safety features

A parallel trader that covers or removes the original safety features places equivalent ones: a new unique identifier in a Data Matrix and an anti-tampering device that meet the same rules.

Verify before you open

Before breaking the original seal, the trader verifies that the original identifier and anti-tampering device are authentic. Only then may the pack be resealed, for example with a new device over the old one.

Upload and decommission

The new identifiers are uploaded to the European Hub, and the original pack's identifier is taken out of service so the same box cannot be sold twice.

Recalls, thefts and samples

Like a marketing authorisation holder, a parallel distributor handles recalled, withdrawn and stolen packs and free samples in the repository system.

The dates

The timeline, as it stands.

These duties have applied since 9 February 2019. The Commission's question-and-answer document on the safety features is updated from time to time; check the latest version before changing a repackaging process.

Safety features apply, EU-widesince 9 Feb 2019
Greece and Italy join the EU system9 Feb 2025
Italy's transition for stamped packs ends8 Feb 2027
What to do now

Three moves that de-risk the deadline.

01 · Step

Record the original before you open it

Keep the verification result for each original pack, so you can show it was authentic when you broke the seal.

02 · Step

Link the old identifier to the new

Keep a record that ties each original serial to the one you applied, for investigations and recalls.

03 · Step

Check every target market

Each destination market can require its own national number inside the code. Map them before printing.

How Aeroz fits

A chain of custody across two packs.

Repackaging breaks the link between the box the manufacturer made and the box the patient receives. Aeroz keeps a signed record that ties the original pack's verification to the new pack's identity, and adds a physical identity a pharmacist can check with a tap.

FAQ

EU FMD for parallel distributors, answered.

Can a parallel trader remove the original safety features?

Yes. It may cover or remove them, provided it places equivalent safety features on the pack under Article 47a of Directive 2001/83/EC.

Can an opened pack be resealed?

Yes, provided the original identifier and anti-tampering device were verified as authentic before the pack was opened. A new device can then be placed over the original.

Do parallel distributors upload to the hub?

Yes. Parallel distributors connect to the European Hub and upload the identifiers they apply, as manufacturers do.

What happens to the original identifier?

It is decommissioned, so the original serial cannot be dispensed again.

Readiness audit

Know exactly where you stand, in 14 days.

A fixed-fee Aeroz audit maps your products against EU FMD duties for parallel distributors: equivalent safety features, re-sealing and hub uploads and returns a written readiness assessment, a data-mapping review, and a scoped pilot plan with cost and timeline.

Fixed fee: Readiness Report $2,500, Readiness Audit $4,500 14-day written report No commitment to proceed